15 Cushing
Irvine, CA 92618
United States
949 409 7600
https://www.oncocyte.com
Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 43
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Joshua Riggs | President, CEO & Director | 504.63k | N/A | 1983 |
Mr. James Liu | Senior Director, Controller, Principal Accounting Officer & Interim Principal Financial Officer | 259.83k | N/A | 1996 |
Dr. Ekkehard Schutz M.D., Ph.D. | Chief Science Officer | 409.27k | N/A | N/A |
Mr. Peter Hong | VP, General Counsel & Secretary | N/A | N/A | N/A |
Mr. Yuh-Min Chiang Ph.D. | Senior Vice President of R&D and Product Development | N/A | N/A | N/A |
Ms. Sandra O'Donald | Senior Vice President of Business Operations | N/A | N/A | N/A |
Dr. Michael D. West Ph.D. | Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc. | N/A | N/A | 1953 |
OncoCyte Corporation, a precision diagnostics company, focuses on development and commercialization of proprietary tests in the United States and internationally. The company is developing DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies; DetermaCNI, a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients; and VitaGraft, a blood-based solid organ transplantation monitoring test. It also provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. (Bio-Rad) to collaborate in the development and the commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
OncoCyte Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.